| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2007 | WO2007059356A3 Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1 |
| 07/19/2007 | WO2007058998A3 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 07/19/2007 | WO2007058873A3 Imidazopyrazines as cyclin depentend kinase inhibitors |
| 07/19/2007 | WO2007058338A3 Oxazole compound and pharmaceutical composition |
| 07/19/2007 | WO2007056439A8 Salts of methylene blue and its derivatives |
| 07/19/2007 | WO2007054453A3 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa |
| 07/19/2007 | WO2007053725A3 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 07/19/2007 | WO2007053685A3 Methods of treating atrial fibrillation with p38 inhibitor compounds |
| 07/19/2007 | WO2007048219A3 Sustained drug release composition |
| 07/19/2007 | WO2007047406A3 Liquid pharmaceutical compositions of nimodipine |
| 07/19/2007 | WO2007044435A3 Treatment of peripheral arterial occlusive disease |
| 07/19/2007 | WO2007041052B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/19/2007 | WO2007035722A3 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 07/19/2007 | WO2007035198A3 Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor |
| 07/19/2007 | WO2007025613A3 Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain |
| 07/19/2007 | WO2007022121A3 O-nitro compounds, pharmaceutical compositons thereof and uses thereof |
| 07/19/2007 | WO2007017828A3 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 07/19/2007 | WO2007016656A8 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 07/19/2007 | WO2007016643A3 A method for extending longevity using npc1l1 antagonists |
| 07/19/2007 | WO2007014673A3 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 07/19/2007 | WO2007012022A3 Unit dose form with ibuprofen-famotidine admixture |
| 07/19/2007 | WO2007009083A3 Compounds with activity at retinoic acid receptors |
| 07/19/2007 | WO2007007207A3 Pharmaceutical compositions of 3, 5 -bis (arylidene) -4 -piperidones and analogues there of for modulating cell proliferation |
| 07/19/2007 | WO2006133835A3 Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin |
| 07/19/2007 | WO2006133523A3 Improved antimicrobial peroxidase compositions |
| 07/19/2007 | WO2006131326A3 Novel use of (-)-epigallocatechin gallate |
| 07/19/2007 | WO2006130553A3 Hcv protease inhibitors |
| 07/19/2007 | WO2006125651A3 Ligustilide derivatives for the treatment of inflammatory disorders |
| 07/19/2007 | WO2006113703A8 Carboline derivatives useful in the treatment of cancer |
| 07/19/2007 | WO2006113431A3 Dual functional oligonucleotides for use as anti-viral agents |
| 07/19/2007 | WO2006105372A3 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 07/19/2007 | WO2006089067A3 Boron-containing small molecules |
| 07/19/2007 | WO2006042751A3 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 07/19/2007 | WO2006037623A3 New nuclear transcription factors regulators |
| 07/19/2007 | WO2006016828A8 Use of alpha ketoglutarate for treating alzheimer, parkinson |
| 07/19/2007 | WO2006007310A3 Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids |
| 07/19/2007 | WO2005120546A3 Compositions and methods for topical diagnostic and therapeutic transport |
| 07/19/2007 | WO2005072057A3 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 07/19/2007 | WO2005033661A3 Dmbt1 as a clinical marker and uses thereof |
| 07/19/2007 | US20070167630 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-Acetoxy-2-benzoyloxy-5,20-epoxy-1,13-dihydroxy-9,10-[(1S)-2-propenylidenedioxy]tax-6,11-diene; antitumor compounds; using low toxic and inexpensive materials; product is readily purified; industrial production |
| 07/19/2007 | US20070167629 improved process from intermediate tert. butyl 3-(4-(5-ethyl-2-pyridyl)ethyloxy)phenyl-2-hydroxypropanoate; or starting reacting 4-phenoxybenzaldehyde and tert.butyl chloroacetate, epoxidation, decyclization, then reacting with 5-ethylpyridine-2-ethyl mesylate to form the intermediate |
| 07/19/2007 | US20070167619 Novel uses of porphyrin compounds |
| 07/19/2007 | US20070167530 Method for depletion of sulphur and/or compounds containing sulphur from a biochemically produced organic compound |
| 07/19/2007 | US20070167529 Antimicrobial compositions for treating fabrics and surfaces |
| 07/19/2007 | US20070167528 Methods of treating hepatocellular carcinoma with denspm |
| 07/19/2007 | US20070167527 Memantine for the normalization of visual acuity deficits |
| 07/19/2007 | US20070167526 Topical mecamylamine formulations for ocular administration and uses thereof |
| 07/19/2007 | US20070167525 Combinations of metformin and a meglitinide |
| 07/19/2007 | US20070167524 Phenylhept-6-yne-acid-4-hydroxy-3-methoxylbenzylamide (phenylcapsaicin); use as microorganism repellent agents in paints and coatings, for marine installations and ships, but also for land-based structures; nontoxic |
| 07/19/2007 | US20070167523 Mixing HCl with a nateglinide mixture formed by reacting trans-4-isopropylcyclohexylcarbonyl chloride with D-phenylalanine in acetone, H2O and KOH; adjusting temperature to 63-65 degrees C. and concentration of acetone 8-22 wt %, and cooling the second reaction mixture to precipitatate the crystals |
| 07/19/2007 | US20070167522 Branched carboxylic acid compound and use thereof |
| 07/19/2007 | US20070167521 Novel structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties |
| 07/19/2007 | US20070167520 purification of unsaturated polyfatty acid to stabilize and prevent reaction and oxidation; use as health dietetics |
| 07/19/2007 | US20070167519 Novel Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof |
| 07/19/2007 | US20070167518 Anti-tussive and bronchodilator actions of Enaminone E121 |
| 07/19/2007 | US20070167517 Stabilized derivatives of ascorbic aicd |
| 07/19/2007 | US20070167516 Methods of using l-butylphthalide for the prevention and treatment of cerebral ischemia disease |
| 07/19/2007 | US20070167515 e.g. iodomethylene-dimethyl-dihydropyranone; novelty of the chemical structure and of the mechanism of action; alkylation aldehyde with methyl [bis(2,2,2-trifluoroethyl)phosphinoyl]acetate followed by cyclization |
| 07/19/2007 | US20070167514 Cannabinoid derivatives, methods of making, and use thereof |
| 07/19/2007 | US20070167513 Crystalline forms of duloxetine free base |
| 07/19/2007 | US20070167512 Lipid metabolism improving agent |
| 07/19/2007 | US20070167511 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 07/19/2007 | US20070167510 Methods for inhibiting osteoclastogenesis |
| 07/19/2007 | US20070167509 Use of phenserine and analogs to treat behavioral problems and improve trainability |
| 07/19/2007 | US20070167507 4-Carbox pyrazole derivatives useful as anti-viral agents |
| 07/19/2007 | US20070167506 Parasiticides of alpha-substituted 2-benzylimidazoles, e.g., 2-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;insecticides; mitacides; ticks and varroa mites; animals; livestock; nontoxic; selectivity for the octopaminergic receptor; pharmakinetics; speed of action; topical spreading; solubility |
| 07/19/2007 | US20070167505 Substituted benzimidazoles and their use for inducing apoptosis |
| 07/19/2007 | US20070167504 Viral hepatitis treatment |
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents |
| 07/19/2007 | US20070167502 Association between a heterocyclic compound and an antioxidant agent |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167500 Remedy for urinary tract diseases |
| 07/19/2007 | US20070167499 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 07/19/2007 | US20070167498 Carboxylic acid compounds |
| 07/19/2007 | US20070167497 such as N-(3,4-difluorobenzyl)-2-{[(5-methoxypyridin-3-yl)amino]sulfonyl}benzamide, having a cytochrome P450 monooxygenase enzyme system inhibitory activity, capable of increasing the bioavailability or improving the pharmacokinetics of coadministered drugs |
| 07/19/2007 | US20070167496 Roflumilast and glycopyrronium combination |
| 07/19/2007 | US20070167495 Pleuromutilin derivatives, process for their preparation and uses thereof |
| 07/19/2007 | US20070167494 Process for preparing a polymorph or rosiglitazone maleate |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 07/19/2007 | US20070167489 Combination comprising antimuscarinic agents and PDE4 inhibitors |
| 07/19/2007 | US20070167488 Novel therapeutic use |
| 07/19/2007 | US20070167487 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/19/2007 | US20070167486 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring |
| 07/19/2007 | US20070167485 N-benzyl-4-{[(1R)-1,2-dimethylpropyl]amino}-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; phosphodiesterase inhibitor; antiinflammatory, antiallergenic agent; chronic obstructive pulmonary disease (COPD), asthma, or rhinitis |
| 07/19/2007 | US20070167484 6-Alkoxy-pyrido-pyrimidines |
| 07/19/2007 | US20070167483 Phenylalanine Enamide Derivatives |
| 07/19/2007 | US20070167482 Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors |
| 07/19/2007 | US20070167481 Imidazonaphthyridines |
| 07/19/2007 | US20070167480 Pure and stable tiotropium bromide |
| 07/19/2007 | US20070167479 Immune response modifier formulations and methods |
| 07/19/2007 | US20070167478 Biomarkers for sensitivity of proliferative diseases to mtor inhibitors |
| 07/19/2007 | US20070167477 Processes to prepare finasteride polymorphs |
| 07/19/2007 | US20070167476 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds |
| 07/19/2007 | US20070167475 Novel Processes for the Production of Useful Intermediates |
| 07/19/2007 | US20070167474 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/19/2007 | US20070167473 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 07/19/2007 | US20070167472 2-Methoxy-ethanesulfamic acid [6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-5-(2-chloro-5-methoxy-phenoxy)-pyrimidin-4-yl]-amide; vasoconstrictor, mediator of cardiac, renal, endocrine functions; neurotransmitter release, activation of inflammatory cells, fibrosis, cell proliferation and differentiation |
| 07/19/2007 | US20070167471 Substituted quinazoline compounds useful as p38 kinase inhibitors |
| 07/19/2007 | US20070167470 Spiro compounds and methods of use |